Newly identified ‘metabolic signature’ can determine adherence to Mediterranean diet, help predict CVD risk

By Nikki Hancocks

- Last updated on GMT

Getty | MarianVejcik
Getty | MarianVejcik

Related tags CVD Mediterranean diet Research

A newly identified “metabolic signature” can evaluate an individual’s adherence and metabolic response to the Mediterranean diet and help predict future risk of developing cardiovascular disease (CVD), according to new research.

The research, published online in the European Heart Journal​, discovered a metabolic signature consisting of 67 metabolites - small chemicals produced in the processes of metabolism that circulate in the bloodstream - that can be measured through a blood sample.

The team, led by researchers from Harvard T.H. Chan School of Public Health with collaborators from the Broad Institute of MIT and Harvard and Spain, used a machine-learning model to analyse hundreds of metabolites in blood samples from 1,859 participants from the Spanish PREDIMED study, the largest study of the Mediterranean diet’s ability to prevent CVD.

The model identified 67 metabolites that, when analysed, collectively indicated whether a person had followed the Mediterranean diet and showed how the person responded to the diet, which is high in unsaturated fats and emphasises plant-based foods, fish, and olive oil, and has been shown to be effective in reducing the risk of CVD and overall mortality.

The study also showed that a higher level of the metabolic signature was associated with a lower long-term risk of CVD among PREDIMED study participants. Even after accounting for traditional CVD risk factors, the metabolic signature was effective at predicting long-term risk of CVD, the researchers said.

The researchers further tested and verified the metabolic signature in blood samples from 6,868 participants from the U.S.-based Nurses’ Health Study, Nurses’ Health Study II, and Health Professional’s Follow-Up Survey.

They noted that ability for the signature to determine adherence and metabolic response to the Mediterranean diet, and to predict future CVD risk, were highly reproducible across all the study populations despite the fact that individuals living in Spain and in the U.S. have different dietary habits, lifestyles, and environmental exposures.

Liming Liang, associate professor of epidemiology and biostatistics at Harvard Chan School and co-senior author of the paper, said: “This study is the first to develop a metabolic signature for the Mediterranean diet based on comprehensive metabolomic profiles. It demonstrates that the level of dietary adherence and individual’s response to diet can be objectively measured.

"The reproducibility of the findings in the U.S. and Spanish populations indicate the robustness of the approach.”

Assessing adherence to the Mediterranean diet has often relied on self-reported data obtained through questionnaires of study participants. The newly discovered metabolic signature could prove to be a potent and objective tool for the research community to further evaluate individuals’ adherence and metabolic response to the Mediterranean diet in various study populations and settings.

Jun Li, research scientist of nutrition and epidemiology at Harvard Chan School and the first author of the paper, said: “The metabolic signature and metabolites included in the signature could also help researchers better understand how the Mediterranean diet can benefit people with complex metabolic diseases. 

“Given that the metabolic signature is reflective of individuals’ metabolic response to diet and CVD risk, the signature has potential in the future to help facilitate personalised nutrition interventions.”

Miguel A. Martinez-Gonzalez, Professor at the University of Navarra (Spain) and coauthor of this study, added: “From a public health perspective, our findings underscored the beneficial effects of the Mediterranean diet for the prevention of cardiovascular disease at a molecular level.” 

Source: European Heart Journal

Liang. L., et al 

“The Mediterranean diet, plasma metabolome, and cardiovascular disease risk”

doi: 10.1093/eurheartj/ehaa209

Related news

Related products

show more

Nextida: Precision where it matters

Nextida: Precision where it matters

Content provided by Rousselot | 01-Jun-2024 | Product Brochure

NEXTIDA™ is an innovative platform of specific collagen peptide compositions with new targeted health benefits. Built and backed by science, Nextida stands...

New digestive wellness solution with clinical evidence

New digestive wellness solution with clinical evidence

Content provided by Symrise AG | 31-May-2024 | Product Brochure

16% of adults across the globe are suffering from constipation¹. Functional gastrointestinal disorders are a worldwide issue, impacting the life of 15,2%...

Related suppliers

Follow us


View more